Association of Schistosoma haematobium infection morbidity and severity on co-infections in pre-school age children living in a rural endemic area in Zimbabwe.

Acute respiratory infection Communicable diseases Dermatophytosis Fever of unknown origin Pneumonia Pre-school age children Schistosomiasis Under-5 mortality rate

Journal

BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562

Informations de publication

Date de publication:
19 Oct 2020
Historique:
received: 23 03 2020
accepted: 29 09 2020
entrez: 20 10 2020
pubmed: 21 10 2020
medline: 15 5 2021
Statut: epublish

Résumé

Individuals living in Schistosoma haematobium endemic areas are often at risk of having other communicable diseases simultaneously. This usually creates diagnostic difficulties leading to misdiagnosis and overlooking of schistosomiasis infection. In this study we investigated the prevalence and severity of coinfections in pre-school age children and further investigated associations between S. haematobium prevalence and under 5 mortality. A community based cross-sectional survey was conducted in Shamva District, Zimbabwe. Using random selection, 465 preschool age children (1-5 years of age) were enrolled through clinical examination by two independent clinicians for the following top morbidity causing conditions: respiratory tract infections, dermatophytosis, malaria and fever of unknown origin. The conditions and their severe sequels were diagnosed as per approved WHO standards. S. haematobium infection was diagnosed by urine filtration and the children were screened for conditions common in the study area which included HIV, tuberculosis, malnutrition and typhoid. Data was analysed using univariate and multinomial regression analysis and relative risk (RR) calculated. Prevalence of S. haematobium was 35% (145). The clinical conditions assessed had the following prevalence in the study population: upper respiratory tract infection 40% (229), fever of unknown origin 45% (189), dermatophytosis 18% and malaria 18% (75). The odds of co-infections observed with S. haematobium infection were: upper respiratory tract infection aOR = 1.22 (95% CI 0.80 to 1.87), dermatophytosis aOR = 4.79 (95% CI 2.78 to 8.25), fever of unknown origin aOR = 10.63 (95% CI 6.48-17.45) and malaria aOR = 0.91 (95% CI 0.51 to1.58). Effect of schistosomiasis coinfection on disease progression based on the odds of the diseases progressing to severe sequalae were: Severe pneumonia aOR = 8.41 (95% CI 3.09-22.93), p < 0.0001, complicated malaria aOR = 7.09 (95% CI 1.51-33.39), p = 0.02, severe dermatophytosis aOR = 20.3 (95% CI 4.78-83.20):p = 0.03, and fever of unknown origin aOR = 1.62 (95%CI 1.56-4.73), p = 0.02. This study revealed an association between schistosomiasis and the comorbidity conditions of URTI, dermatophytosis, malaria and FUO in PSAC living in a schistosomiasis endemic area. A possible detrimental effect where coinfection led to severe sequels of the comorbidity conditions was demonstrated. Appropriate clinical diagnostic methods are required to identify associated infectious diseases and initiate early treatment of schistosomiasis and co-infections in PSAC.

Sections du résumé

BACKGROUND BACKGROUND
Individuals living in Schistosoma haematobium endemic areas are often at risk of having other communicable diseases simultaneously. This usually creates diagnostic difficulties leading to misdiagnosis and overlooking of schistosomiasis infection. In this study we investigated the prevalence and severity of coinfections in pre-school age children and further investigated associations between S. haematobium prevalence and under 5 mortality.
METHODS METHODS
A community based cross-sectional survey was conducted in Shamva District, Zimbabwe. Using random selection, 465 preschool age children (1-5 years of age) were enrolled through clinical examination by two independent clinicians for the following top morbidity causing conditions: respiratory tract infections, dermatophytosis, malaria and fever of unknown origin. The conditions and their severe sequels were diagnosed as per approved WHO standards. S. haematobium infection was diagnosed by urine filtration and the children were screened for conditions common in the study area which included HIV, tuberculosis, malnutrition and typhoid. Data was analysed using univariate and multinomial regression analysis and relative risk (RR) calculated.
RESULTS RESULTS
Prevalence of S. haematobium was 35% (145). The clinical conditions assessed had the following prevalence in the study population: upper respiratory tract infection 40% (229), fever of unknown origin 45% (189), dermatophytosis 18% and malaria 18% (75). The odds of co-infections observed with S. haematobium infection were: upper respiratory tract infection aOR = 1.22 (95% CI 0.80 to 1.87), dermatophytosis aOR = 4.79 (95% CI 2.78 to 8.25), fever of unknown origin aOR = 10.63 (95% CI 6.48-17.45) and malaria aOR = 0.91 (95% CI 0.51 to1.58). Effect of schistosomiasis coinfection on disease progression based on the odds of the diseases progressing to severe sequalae were: Severe pneumonia aOR = 8.41 (95% CI 3.09-22.93), p < 0.0001, complicated malaria aOR = 7.09 (95% CI 1.51-33.39), p = 0.02, severe dermatophytosis aOR = 20.3 (95% CI 4.78-83.20):p = 0.03, and fever of unknown origin aOR = 1.62 (95%CI 1.56-4.73), p = 0.02.
CONCLUSION CONCLUSIONS
This study revealed an association between schistosomiasis and the comorbidity conditions of URTI, dermatophytosis, malaria and FUO in PSAC living in a schistosomiasis endemic area. A possible detrimental effect where coinfection led to severe sequels of the comorbidity conditions was demonstrated. Appropriate clinical diagnostic methods are required to identify associated infectious diseases and initiate early treatment of schistosomiasis and co-infections in PSAC.

Identifiants

pubmed: 33076903
doi: 10.1186/s12889-020-09634-0
pii: 10.1186/s12889-020-09634-0
pmc: PMC7574170
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1570

Subventions

Organisme : National Institute of Health Research
ID : 16/136/33

Références

PLoS Negl Trop Dis. 2018 Feb 8;12(2):e0006144
pubmed: 29420537
Adv Parasitol. 2011;77:1-85
pubmed: 22137582
Infect Dis Poverty. 2018 Apr 30;7(1):41
pubmed: 29706131
Lancet Glob Health. 2019 Oct;7(10):e1414-e1422
pubmed: 31537371
J Infect Dis. 2008 Jul 15;198(2):167-75
pubmed: 18549316
Trop Med Int Health. 2014 Sep;19 Suppl 1:7-131
pubmed: 25214480
J Helminthol. 2012 Sep;86(3):323-8
pubmed: 22824258
Eur Respir Rev. 2015 Jun;24(136):187-93
pubmed: 26028631
Tropenmed Parasitol. 1982 Dec;33(4):227-8
pubmed: 7164164
PLoS Negl Trop Dis. 2014 Aug 14;8(8):e3014
pubmed: 25121489
Mycopathologia. 2008 Nov-Dec;166(5-6):277-83
pubmed: 18478362
BMC Infect Dis. 2019 Feb 27;19(1):198
pubmed: 30813923
Parasitology. 2014 Dec;141(14):1962-70
pubmed: 24679476
Asian Pac J Allergy Immunol. 2011 Jun;29(2):113-9
pubmed: 21980825
Trop Med Int Health. 2020 Sep;25(9):1110-1121
pubmed: 32502300
Biomed Res Int. 2014;2014:375862
pubmed: 25045666
BMC Public Health. 2019 Apr 11;19(1):392
pubmed: 30971223
Braz J Infect Dis. 2015 Mar-Apr;19(2):196-205
pubmed: 25636189
BMJ Glob Health. 2018 Mar 27;3(2):e000661
pubmed: 29616147
Clin Microbiol Rev. 2005 Jan;18(1):30-43
pubmed: 15653817
Rev Soc Bras Med Trop. 2017 Jan-Feb;50(1):141-144
pubmed: 28327819
BMC Infect Dis. 2019 Jul 22;19(1):653
pubmed: 31331269
Bacteriol Rev. 1974 Jun;38(2):222-50
pubmed: 4134809
PLoS Negl Trop Dis. 2011 May;5(5):e1143
pubmed: 21610855
Curr Opin Infect Dis. 2004 Oct;17(5):439-47
pubmed: 15353964
Acta Trop. 2010 Feb;113(2):95-104
pubmed: 19962954
Postgrad Med. 1964 Dec;36:555-9
pubmed: 14234314

Auteurs

Tariro L Mduluza-Jokonya (TL)

Optics & Imaging, Doris Duke Medical Research Institute, College of Health Sciences, University of KwaZulu-Natal, Durban, KwaZulu-Natal, South Africa. tljokonya@gmail.com.
Department of Biochemistry, University of Zimbabwe, P.O. Box MP 167, Mt Pleasant, Harare, Zimbabwe. tljokonya@gmail.com.

Thajasvarie Naicker (T)

Optics & Imaging, Doris Duke Medical Research Institute, College of Health Sciences, University of KwaZulu-Natal, Durban, KwaZulu-Natal, South Africa.

Luxwell Jokonya (L)

Optics & Imaging, Doris Duke Medical Research Institute, College of Health Sciences, University of KwaZulu-Natal, Durban, KwaZulu-Natal, South Africa.
Department of Surgery, College of Health Sciences, University of Zimbabwe, P.O. Box MP 167, Mt Pleasant, Harare, Zimbabwe.

Herald Midzi (H)

Optics & Imaging, Doris Duke Medical Research Institute, College of Health Sciences, University of KwaZulu-Natal, Durban, KwaZulu-Natal, South Africa.

Arthur Vengesai (A)

Optics & Imaging, Doris Duke Medical Research Institute, College of Health Sciences, University of KwaZulu-Natal, Durban, KwaZulu-Natal, South Africa.

Maritha Kasambala (M)

Department of Biochemistry, University of Zimbabwe, P.O. Box MP 167, Mt Pleasant, Harare, Zimbabwe.

Emilia Choto (E)

Department of Biochemistry, University of Zimbabwe, P.O. Box MP 167, Mt Pleasant, Harare, Zimbabwe.

Simbarashe Rusakaniko (S)

Department of Community Medicine, College of Health Sciences, University of Zimbabwe, P.O. Box MP 167, Mt Pleasant, Harare, Zimbabwe.

Elopy Sibanda (E)

Twin Palms Medical Centre, 113 Kwame Nkrumah Avenue, Harare, Zimbabwe.

Francisca Mutapi (F)

Institute for Immunology and Infection Research and Centre for Immunity, Infection and Evolution, School of Biological Sciences, University of Edinburgh, Ashworth Laboratories, King's Buildings, Charlotte Auerbach Rd., Edinburgh, EH9 3JT, UK.

Takafira Mduluza (T)

Optics & Imaging, Doris Duke Medical Research Institute, College of Health Sciences, University of KwaZulu-Natal, Durban, KwaZulu-Natal, South Africa.
Department of Biochemistry, University of Zimbabwe, P.O. Box MP 167, Mt Pleasant, Harare, Zimbabwe.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH